Description of Characteristics, Main Complaints, Duration of Treatment, Complications and Comorbidities in Covid-19 Patients at Tk.II Dustira

The 2019 coronavirus disease was declared a pandemic by the World Health Organization in March 2020. By 2021, Indonesia had a total of 4,262,720 cases and 142,560 deaths. By 2021, the total number of confirmed COVID-19 cases grew to 4,262,720. Since the deaths due to the coronavirus amounted to 144,094, clinical manifestations in patients with COVID-19 have a wide spectrum, ranging from no to severe symptoms. Most patients have symptoms such as fever, cough, sneezing, and shortness of breath. Age, gender, accompanying diseases, clinical symptoms, and laboratory parameters are all related to the duration of treatment for COVID-19 patients; comorbidities can cause complications such as hypertension, heart disease, chronic kidney disease, and chronic lung disease. The research draft used in this study is descriptive. Previous research showed that the age of most participants (55%) was 50 years and 59% were male, 91% had respiratory complaints, 90% had a respiratory cough, 94% had a non-respiratory fever, the treatment length was 6–11 days in 68%, bronchopulmonary pneumonia as a complication was seen in 43%, and comorbid hypertension was reported in 35%. The results of the study showed that elderly patients are at greater risk of getting infected with COVID-19, and respiratory complaints are the most common because COVID-19 attacks the reproductive organs, and fever is a manifestation of the infection of the body with the virus. Hypertension is the most common comorbidity that causes the activation of COVID-19 caused by ACE 2. Keywords: Covid-19, primary complaint, treatment length, complication, comorbid